The study explores antibacterial, antiinflammatory and cytoprotective capacity of 21 Pelargonium sidoides DC root extract (PSRE) and proanthocyanidin fraction from PSRE (PACN) 22 under conditions characteristic for periodontal disease. Following previous finding that PACN 23 exerts stronger suppression of Porphyromonas gingivalis compared to the effect on commensal 24 Streptococcus salivarius, the current work continues antibacterial investigation on Staphylococcus 25 aureus, Staphylococcus epidermidis, Aggregatibacter actinomycetemcomitans and Escherichia coli. PSRE 26 and PACN are also studied for their ability to prevent gingival fibroblast cell death in the 27 presence of bacteria or bacterial lipopolysaccharide (LPS), to block LPS-or LPS+IFN-induced 28 release of inflammatory mediators, gene expression and surface antigen presentation. Both PSRE 29 and PACN were more efficient in suppressing Staphylococcus and Aggregatibacter compared to 30 Escherichia, prevented A. actinomycetemcomitans-and LPS-induced death of fibroblasts, 31 decreased LPS-induced release of interleukin-8 and prostaglandin E2 from fibroblasts and IL-6 32 from leukocytes, blocked expression of IL-1β, iNOS, and surface presentation of CD80 and CD86 33 in LPS+IFNγ-treated macrophages, and IL-1β and COX-2 expression in LPS-treated leukocytes.
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All treatments were made simultaneously, without pre-incubations, and lasted 24 h. LPS was used at 145 concentration of 2 mg/mL (1 mg/mL LPS did not induce significant increase in cell death), filtered 146 PSRE and PACN solutions at 50 and 100 g/mL (both preparations induced toxicity starting from 147 200 g/mL). 148 2.6. Bone marrow-derived macrophages 149 For bone marrow-derived macrophages (BMDM) isolation male C57BL6/J inbred mice (18) (19) (20) 150 weeks old, Envigo, Netherlands) were used. The experimental procedures were carried out in 151 accordance with the guidelines of the European Community (2010/63/EU), local laws and policies and 152 were approved by the Latvian Animal Protection Ethical Committee, Food and Veterinary Service, 153 Riga, Latvia. Mice were euthanized by decapitation, and bone marrow cells were extracted from femur 154 bones and differentiated for 7 days in RPMI-1640 with Glutamax (Gibco,) supplemented with 10% 155 FBS, 1% antibiotics and 10 ng/mL M-CSF (monocyte-colony stimulating factor, PeproTech, London, 156 UK). Then cells were detached by 0,5% trypsin (Sigma Aldrich), and plated in a 12-well plate (11x10 5 157 cells/mL) in DMEM-high glucose medium supplemented with 10% FBS, 1% antibiotics. After 1h 158 incubation in 37°C incubator, cells were stimulated with PSRE and PACN at 100 µg/mL and LPS 10 159 ng/mL with murine IFNγ (interferon gamma, PeproTech) 100 U/mL for proinflammatory gene 160 expression and macrophage polarization to M1 (pro-inflammatory) phenotype for 2 h and 24 h, 
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Medium collected after treatments was assayed for cytokines tumour necrosis factor-α (TNF-α),
205
interleukin-6 (IL-6), interleukin-8 (IL-8) and prostaglandin E2 (PGE2) production using TNF-α mouse 206 (Millipore), IL-6 human (Sabbiotech), IL-8 rat (Abbexa) and PGE2 rat (Abbexa) kits following the 207 manufacturer's protocols. The quantitative results are presented as mean ± standard deviation (SD) of 3-7 replicates. The 231 statistical data analysis was evaluated by applying the ANOVA with Tukey HSD post hoc test.
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Differences were considered statistically significant when p < 0.05. The data were processed using 
246
Both PSRE and PACN significantly reduced bacterial metabolic activity in comparison to the 247 untreated control, starting from concentrations of 50-70 g/mL. However, some differences were 248 noticed between the tested strains. In the case of S. aureus, PSRE was more effective than PACN 249 ( Fig. 1a ). 50 g/mL of PSRE was enough to significantly decreased metabolic activity of this strain,
250
whereas PACN had similar result at 80 g/mL (p<0.05 vs control, indicated by the *). For
251
A. actinomycetemcomitans, the results were opposite (Fig. 1d) ; PACN significantly decreased metabolic 252 activity at 50 g/mL, but it was required 80 g/mL PSRE to achieve this level of activity. The 253 metabolism of the clinical isolate S. epidermidis (Fig. 1b ) was significantly decreased by both PSRE and 254 PACN applied at 70 g/mL concentration.
255
Interestingly, the non-pathogen E. coli has demonstrated the highest resistance to the treatment 256 ( Fig. 1c ). After 80 g/mL PSRE treatment, metabolic activity of E. coli decreased by 26% compared 257 with untreated control, whereas metabolic activity of S. aureus, S. epidermidis and 258 A. actinomycetemcomitans was reduced by 75%, 97%, and 57%, accordingly. In the presence of 80 7 of 19 g/mL PACN, the loss of metabolic activity of these four strains listed in the same order was 47%, 260 74%, 96%, and 99%. Moreover, even after addition of 100 g/mL PACN to the growth medium, E. coli 261 still preserved nearly half of the control activity level, but in the case of A. actinomycetemcomitans, the 262 twice less amount of this preparation almost completely blocked bacterial growth. Summarizing, the 263 results of antibacterial evaluation indicate stronger toxicity of PSRE and PACN to pathogens than to 264 non-pathogenic E. coli strain. 
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Both the presence of PSRE and PACN at 100 g/mL were effective in protecting cells from 282 bacterial infection; the number of viable cells counted after 24 h of direct contact with bacteria was 283 comparable with the control consisting of cells cultivated in fresh medium without bacterial presence.
284
Conversely, when bacteria were cultivated in the same wells of cells but in the absence of PSRE or 285 PACN (no treatment), they were able to fully colonize the well. In this scenario, no viable cells were 286 detected for both applied models. The results indicate that the presence of either of the substances 287 was effective in preserving gingival fibroblast cell viability by lowering bacteria proliferation. 
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After treatment with 2 g/mL LPS, the amount of necrotic cells with propidium iodide-positive 306 nuclei in fibroblast cell culture increased from 2.7±2.2% in control to 31.7±11.9%, reflecting statistically 307 significant loss in cell viability (Fig. 3) . However, the treatments with 50 and 100 g/mL PSRE and 
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There are two main groups of caspases according to their place in the apoptotic event cascade:
323
initiator caspases acting as apoptotic triggers and effector caspases that are amplified by triggers and 
333
After treatment with LPS, effector caspase-3 substrate cleavage rate increased from 0.012±0.01 to 334 0.189±0.06 nmol/min/mg (Fig. 4, b 
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Increased IL-8 production by gingival fibroblasts is responsible for attraction of neutrophils to 363 inflamed regions and rapid tissue loss during periodontitis [24, 25] . Evaluation of IL-8 amounts 364 secreted in the medium by cultured gingival fibroblasts revealed that after 24 h with LPS the amount 365 of the cytokine has increased from nearly zero to 1022±75 ng/mL (Fig. 5 a) . In the presence of 50 g/mL 366 PSRE, the level of IL-8 after same LPS stimulation was only 344±49 ng/mL, i.e., 3 times lower than 
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The level of PGE2, a mediator of cyclooxygenase-2 inflammatory pathway, was found to be 380 dramatically increased in the cell culture medium after LPS treatment (Fig. 5 b) 
391
induced secretion of IL-6 from PBMCs to 67% and 18% of the level caused by LPS stimulation, 392 respectively (Fig. 5 c) . Note that neither PSRE nor PACN were toxic to the cells at the concentrations 393 applied as revealed by metabolic viability analysis (Supplemetary Figure S2 ).
394
The data about inflammatory mediator secretion indicate that both PSRE and PACN efficiently 395 suppress LPS-induced IL-8 and PGE2 release from gingival fibroblasts and IL-6 release from 396 mononuclear leukocytes. PACN has slightly stronger IL-8 and IL-6 release suppressing activity, and 397 significantly stronger PGE2 release suppressing activity than PSRE. 
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of A. actinomycetemcomitans nearly 10 times more if compared to the untreated control value (Fig.1 d) .
490
The same concentration had no significant toxicity on other investigated strains. The minimal amount only to host protection against bacterial attachment, but also to making the membranes of the 506 pathogens more permeable and their inner systems more vulnerable. However, further studies are 507 required to find out binding affinity of PACN to LPS of different bacterial strains as well as precise 508 mechanism and signalling pathways of this interaction.
509
Bacterial infection simulation in the co-culture "race for the surface" assay revealed that addition 510 of 100 g/mL of either PSRE or PACN in the medium was effective in preserving viability of human 511 gingival fibroblasts in the presence of both S. aureus and A. actinomycetemcomitans (Fig. 2) . Similarly, 
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In conclusion, both investigated substances revealed antibacterial and antiinflammatory 566 efficiency in periodontitis mimicking conditions. However, the combination of strong pathogen-567 selective antibacterial, antiinflammatory and gingival tissue protecting properties of PACN suggest 568 this preparation as potential candidate for treatment and prevention of periodontal disease.
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Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1 : The 570 concentration-dependent toxicity of Pelargonium sidoides DC root extract (PSRE) and proanthocyanidins from
